Business News • PR NewsWire • New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition

New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition

New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition

ATLANTA, March 14 /PRNewswire-FirstCall/ -- Late-breaking data presented today at the American College of Cardiology's 59th annual scientific session from the landmark EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) trial demonstrated that Abbott's investigational MitraClip® system me

View More : http://www.prnewswire.com/news-releases/new-data-demonstrates-abbotts-investigational-mitraclipr-system-has-potential-to...

Releted News by prnewswire

Abbott Statement: ACCORD Lipid Results Support Treatment Guidelines for Fibrate Use

NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance

Siemens Highlights Its Commitment to Excellence in Cardiology at ACC 2010